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Abstract
Purpose Previous studies found higher levels of pain severity and disability to be associated with higher costs and lower 
health-related quality of life. However, these findings were based on cross-sectional data and little is known about the longi-
tudinal relationships between pain severity and disability versus health-related quality of life and costs among chronic low 
back pain patients. This study aims to cover this knowledge gap by exploring these longitudinal relationships in a consecu-
tive cohort.
Methods Data of 6316 chronic low back pain patients were used. Measurements took place at 3, 6, 9, and 12 months. Pain 
severity (Numeric pain rating scale; range: 0–100), disability (Oswestry disability index; range: 0–100), health-related quality 
of life (EQ-5D-3L: range: 0–1), societal and healthcare costs (cost questionnaire) were measured. Using linear generalized 
estimating equation analyses, longitudinal relationships were explored between: (1) pain severity and health-related quality 
of life, (2) disability and health-related quality of life, (3) pain severity and societal costs, (4) disability and societal costs, 
(5) pain severity and healthcare costs, and (6) disability and healthcare costs.
Results Higher pain and disability levels were statistically significantly related with poorer health-related quality of life 
(pain intensity: − 0.0041; 95% CI − 0.0043 to − 0.0039; disability: − 0.0096; 95% CI − 0.0099 to − 0.0093), higher societal 
costs (pain intensity: 7; 95% CI 5 to 8; disability: 23; 95% CI 20 to 27) and higher healthcare costs (pain intensity: 3; 95% 
CI 2 to 4; disability: 9; 95% CI 7 to 11).
Conclusion Pain and disability were longitudinally related to health-related quality of life, societal costs, and healthcare 
costs. Disability had a stronger association with all outcomes compared to pain.
Keywords Pain · Disability · Health-related quality of life · Societal costs · Longitudinal analysis · Low back pain
Introduction
Low back pain (LBP) is a highly prevalent health complaint. 
In 2015, the global point prevalence of activity-limiting LBP 
was estimated at 7.3%, implying that about 540 million peo-
ple worldwide were affected by LBP at that moment in time 
[1]. Previous studies reported the lifetime-prevalence of LBP 
to range from 60 to 85% [2–5]. This indicates that people 
have a high probability of developing an LBP episode at any 
time during their life. In the upcoming decades, the aging of 
the population will likely lead to an increased prevalence of 
LBP as well as an increased number of patients whose pain 
persists for a period longer than 3 months (also defined as 
chronic LBP) [6, 7].
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Chronic LBP is associated with high pain levels, signifi-
cant physical limitations, poorer prognosis, lower health-
related quality of life and disability [3, 8–10]. Around 57 
million years lived with disability were found to be associ-
ated with LBP in 2016, and these have increased by more 
than 50% since 1990 [11]. Chronic LBP patients report qual-
ity of life scores that are comparable to those individuals 
with a life-threatening diagnosis [12]. Even though only 
10–15% of LBP patients develop chronic LBP, research 
suggests that chronic LBP is responsible for the majority 
of LBP-related societal costs [6]. In the Netherlands, these 
LBP-related societal costs were estimated to be as high 
as 3.5 billion euros in 2007, which equals about 0.6% of 
the Dutch gross national product (GNP) [6]. In the United 
States, the estimated annual total societal cost of LBP was 
estimated at 100 billion dollars [13, 14]. Absenteeism, early 
retirement, and a loss of productivity while being at work 
are the most important drivers of these societal costs [15].
Previous studies found a higher level of pain severity 
and/or disability to be related to higher costs and a lower 
health-related quality of life [10, 16–19]. A study by Horng 
et al. for example, reported significant correlations between 
pain intensity and disability and health-related quality of 
life [17, 18]. Long lasting, persisting pain and functional 
limitations that LBP patients experience can cause disability 
and interfere with their quality of life [17, 20]. Chiarotto 
et al. reported a positive correlation between pain severity, 
as measured using a Numeric Rating Scale (NRS), and dis-
ability and a negative correlation between pain severity, as 
measured using the brief pain inventory-pain severity, and 
health-related quality of life [21]. Sadosky et al. found that 
an increasing pain severity level was associated with higher 
indirect costs (i.e., productivity-related costs), direct costs 
(i.e., healthcare costs), and societal costs amongst Japanese 
LBP patients [19].
Previous studies on the relation between pain severity and 
disability versus health-related quality of life and health-
care and societal costs among chronic LBP patients were 
cross-sectional in nature [19]. This means that they explored 
whether pain severity and/or disability were associated at a 
certain point in time with health-related quality of life and/
or healthcare and societal costs. Such cross-sectional stud-
ies do not provide insight into whether individual changes 
in one variable (e.g., pain severity) are related to individual 
changes in another (e.g., costs). Such relationships can only 
be studied using a longitudinal study design, in which both 
variables are measured and compared over time [22].
This study aims to cover this knowledge gap by explor-
ing the longitudinal relationships between pain severity and 
disability versus health-related quality of life, healthcare and 
societal costs among chronic LBP patients. Based on previ-
ous cross-sectional research, we expect that higher pain and 
disability are associated with reduced health-related quality 
of life (negative longitudinal relationship) and higher health-
care and societal costs (positive longitudinal relationship). 
Next to providing valuable information for clinical practice, 
information on the longitudinal relationships between pain 
severity and disability versus health-related quality of life 
and costs amongst chronic LBP patients, could provide valu-
able input for health economic modeling studies in the area 
of chronic LBP.
Methods
Study population and design
Data collected during the MinT (minimal invasive treatment) 
study [23] were used to explore the longitudinal relation-
ships between pain severity and disability versus health-
related quality of life and costs among chronic LBP patients. 
The MinT study was conducted in the Netherlands, and con-
sisted of three randomized controlled trials and an observa-
tional study. The overall aim of the MinT study was to assess 
the effectiveness and cost-effectiveness of adding minimal 
interventional procedures to a standardized treatment pro-
gram, compared with a standardized treatment program 
alone [23, 24]. A detailed description of the MinT study 
can be found elsewhere [23]. In the present study, only data 
of chronic LBP patients participating in the observational 
branch of the MinT study were used (i.e., patients experi-
encing LBP symptoms for more than 12 weeks). In order 
to be eligible to participate in the observational study, and 
thus to be included in the present study, patients had to be 
aged between 18 and 70 years, referred to a pain clinic with 
suspected chronic mechanical LBP and without improve-
ment of symptoms after conservative treatment [23]. The 
observational study monitored patients who did not want 
to, or were not eligible, to participate in the aforementioned 
randomized controlled trials [23].
Outcome measures
Dependent variables: health‑related quality of life, societal 
costs, and healthcare costs
Three dependent variables were used in this study, all of 
which were measured at 3, 6, 9, and 12-month follow-up. 
Health-related quality of life was also measured at base-
line, whereas healthcare and societal costs were not. To 
improve comparability across the analyses, only follow-up 
measurement values were used for assessing the longitudinal 
relationships.
(1) Health-related quality of life Health-related quality 
of life was measured using the EQ-5D-3L. The EQ-
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5D-3L is a health-related quality of life scale that 
has previously been found to be responsive amongst 
chronic LBP patients [25]. The EQ-5D-3L consists 
of five dimensions of health, including mobility, self-
care, daily activities, pain/discomfort, and anxiety/
depression, each with three levels of severity. The par-
ticipants’ EQ-5D-3L scores were converted into utility 
values using the Dutch tariff [26]. Utility values are 
preference weights, indicating a person’s value or desir-
ability of a certain health state on a scale anchored at 0 
(equal to death) and 1 (equal to full health) [27].
(2) Societal costs Comprised in societal costs were health-
care, informal care, unpaid productivity and work 
absenteeism costs. Resource use was measured using 
cost questionnaires [28]. Healthcare use included the 
use of primary care (e.g., visits to a general practitioner 
or physiotherapist) and secondary care (e.g., visits to 
a medical specialist or pain clinic). Data from the 
updated Dutch Manual of Costing were used to value 
costs of common healthcare interventions, such as 
appointments with a general physician and a physical 
therapist [29]. Costs of less common interventions were 
estimated using an average of five quotes from vari-
ous practitioners across the country and/or pricelists 
of professional organizations. Informal care and unpaid 
productivity were valued using a recommended Dutch 
shadow price [29]. To measure work absenteeism, the 
Productivity and disease Questionnaire (PRODISQ) 
was used [30]. Absenteeism costs were estimated in 
accordance with the friction cost approach and using 
gender-specific price weights provided by the updated 
Dutch Manual of Costing [29]. All cost categories were 
measured with 3-month recall periods [28].
(3) Healthcare costs Comprised in healthcare costs were 
primary and secondary healthcare costs. The measure-
ment and valuation of healthcare costs has been outline 
above.
Independent variables: pain severity and disability
Two independent variables were used in this study, both 
of which were measured at baseline, 3, 6, 9, and 12-month 
follow-up:
(1) Pain intensity Pain severity was measured using the 
NPRS (range 0—no pain to 10—worst pain imagi-
nable). Scores were transformed to a 0–100 scale to 
improve the interpretation and comparability of out-
comes. Several studies concluded that the validity and 
sensitivity of the NPRS was appropriate for measur-
ing pain in chronic LBP patients [31, 32]. A clinically 
meaningful change for people with LBP on the NPRS 
was previously found to be two (equalling 20 on the 
0–100 scale) [33].
(2) Disability Disability was measured using the Oswestry 
Disability Index (ODI: range 0—no disability to 100—
maximum disability possible). The ODI is a commonly 
used outcome measure amongst LBP patients [34–37] 
and is reported to be a valid, reliable and responsive 
hence suitable as a clinical measure [34]. A clinically 
meaningful change for people with LBP on the ODI 
was previously found to be ten points on the 0–100 
point ODI [38].
The ODI and NPRS are both part of the core outcome set 
recommended for LBP [39].
Potential confounding factors
Potential confounding factors included were based on litera-
ture [40] and measured at baseline. These included:
– Patient expectations (Credibility/Expectancy Question-
naire [CEQ] [41]; range 0—least credibility/expectancy 
to 100—more credibility/expectancy).
– Pain severity (Numeric Pain Rating Scale [NPRS]; range 
0—no pain to 100—worst pain imaginable) [33]. For the 
purpose of this study, scores were transformed to 0–100. 
(In the analyses in which disability and health-related 
quality of life were included).
– Disability (Oswestry Disability Index [ODI]; range 0—
no disability to 100—maximum disability) [36, 42]. (In 
the analyses in which pain and health-related quality of 
life were included).
– Health-related quality of life (EuroQol [EQ-5D-3L]; 
range 0—equal to death 1—equal to full health) [43].
– General health—mental component score and physical 
component score (Rand-36 [Rand-36]; scores range 0—
lowest general health to 100—highest general health) 
[44–46]. The two component scores were assessed for 
being a confounding variable separately.
– Impact of pain experience (Multidimensional Pain Inven-
tory [MPI]; range 0—least/best to 100—most/worst) [47, 
48].
– Education level (low/moderate/high). Low-indicates, no 
education, primary level education, lower vocational and 
lower secondary education, moderate-indicates higher 
secondary education or undergraduate, high-indicates 
tertiary education university or postgraduate).
– Body Mass Index ([BMI], weight in kg/(height in 
meters)2).
– Employment (yes/no).
– Recurrent complaints (yes/no).
– Age (years).
– Gender (male/female).
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– Nationality (Dutch/non-Dutch).
– Smoking (yes/no).
– Type of health care insurance (basic/additional).
– Region of residence (south/north/east/west).
– Married/living together yes/no).
– Diagnosis (sacroiliac joint (SI)/facet/disc/combined/
unclear).
Statistical analysis
The patients’ baseline characteristics were descriptively 
summarized. Missing data were handled using multiple 
imputation to avoid possible bias due to selective drop-out 
of participants [49]. Imputations were performed using 
the Multiple Imputation by Chained Equations algorithm 
with predictive mean matching [50]. The imputation model 
included all available potential confounders, pain intensity, 
disability, health-related quality of life, and cost values.
For answering the research question, linear generalized 
estimating equation (GEE) analyses were performed. A 
GEE analysis is a so-called sophisticated longitudinal data 
analysis technique, in which the relationship between the 
variables in the model (e.g., pain severity and societal costs) 
at different time points (i.e., 3, 6, 9, and 12 months) is ana-
lyzed simultaneously. Herewith, the estimated regression 
co-efficient reflects the longitudinal relationship between 
the dependent variable (e.g., societal costs) and the inde-
pendent variable(s) (e.g., pain severity), using all available 
data, and thus providing an indication of whether changes 
in the dependent variable are related to changes in the inde-
pendent variable [22] within and between participants over 
different measurement time points. Six separate longitudinal 
relationships were assessed between: (1) pain severity and 
health-related quality of life, (2) disability and health-related 
quality of life, (3) pain severity and societal costs, (4) dis-
ability and societal costs, (5) pain severity and healthcare 
costs, and (6) disability and healthcare costs. Longitudinal 
relationships (1) and (2) were explored with a Gaussian 
distribution and an identity link. Longitudinal relationships 
(3) to (6) were explored with a gamma distribution and an 
identity link. The gamma distribution was chosen to take 
into account the right skewed nature of cost data. In all of 
the analyses, an exchangeable correlation structure was 
assumed. First, crude analyses were performed that solely 
included the dependent and the independent variables. Sec-
ond, adjusted analyses were performed that also included 
potential confounding factors. Variables that changed the 
regression co-efficient by more than 10% were deemed con-
founders and were included in the model. All analyses were 
performed in Stata (version 14 SE, Stata Corp). Statistical 
significance was set on p < 0.05.
Results
Participants
Data from 6316 chronic LBP patients were analyzed in the 
present study. Of them, the majority were female (66%), 
overweight (67%), Dutch (95%), had a low level of educa-
tion (56%), had a mean age of 57 years and more than half 
were unemployed (59%) (Table 1). Cost data had the highest 
percentage of missing data and most data were missing at 
9-month follow-up. A detailed description of the percent-
ages of missing data per outcome and per time point can be 
found in Fig. 1.
Disability
Table 2 shows the results from the longitudinal analyses 
between disability and health-related quality of life, soci-
etal costs and healthcare costs. Disability and health-related 
quality of life had a statistically significant negative lon-
gitudinal relationship (B: − 0.0096; 95% CI − 0.0099 to 
− 0.0093). As none of the possible confounding factors 
changed the regression co-efficient by more than 10% an 
adjusted model was not required. The crude analysis using 
disability and societal costs suggested a significant positive 
longitudinal relationship (B: 25; 95% CI 20 to 29). After 
adjusting for confounding, the identified longitudinal rela-
tionship between disability and societal costs remained sta-
tistically significant (B: 23; 95% CI 20 to 27). A significant 
positive longitudinal relationship was also observed in both 
the crude (B: 10; 95% CI 9 to 12) and adjusted (B: 9; 95% 
CI 7 to 11) analyses using disability and healthcare costs.
Pain
Table 3 shows the results from the longitudinal analyses 
between pain and health-related quality of life, societal costs 
and healthcare costs. A significant negative longitudinal 
relationship was observed between pain and health-related 
quality of life. After adjusting for confounding, the results 
still suggested a significant negative longitudinal relation-
ship between pain and healthcare costs (B: − 0.0041; 95% 
CI − 0.0043 to − 0.0039). The crude analyses using pain 
and societal costs suggested a significant positive longitu-
dinal relationship (B: 8; 95% CI 6 to 10). After adjusting 
for confounding, the adjusted analysis also suggested a sig-
nificant positive longitudinal relationship between pain and 
societal costs (B: 7; 95% CI 5 to 8). Pain and healthcare costs 
also had a significant positive longitudinal relationship in 
both the crude (B: 3; 95% CI 2 to 5) and adjusted analysis 
(Beta = B: 2; 95% CI 2 to 4).
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Table 1  Patient characteristics Participant characteristic All patients (n = 6316)
Age (years) [mean (SD)] 57.2 (13,4)
Gender [n (%)]
 Female 4142 (66)
 Male 2093 (34)
BMI [n (%)]
 BMI < 18.5 (underweight) 37 (1)
 BMI ≥ 18.5 < 25 (normal weight) 1687 (32)
 BMI ≤ 25 < 30 (overweight) 2060 (39)
 BMI ≥ 30 (obese) 1463 (28)
Smoking [n (%)]
 Yes 1413 (26)
 No 3920 (73)
Educational level [n (%)]
 Low (no education, primary level education, lower vocational and lower second-
ary education)
2925 (56)
 Moderate (higher secondary education or undergraduate) 1467 (28)
 High (tertiary, university level, postgraduate) 830 (16)
Living together with a partner [n (%)]
 Yes 4663 (75)
 No 1593 (26)
Nationality [n (%)]
 Dutch 5049 (95)
 Non-Dutch: 278 (5.2)
  Surinamese 21 (0.4)
  Antillean/Aruban 22 (0.4)
  Turkish 63 (1)
  Moroccan 42 (1)
  Other 130 (2.4)
Region in the Netherlands [n (%)]
 South 2029 (32)
 North 1165 (19)
 East 1280 (20)
 West 1782 (28)
Employment [n (%)]
 Yes 1687(42)
 No 2376 (59)
Recurrent low back pain [n (%)]
 Yes 3174 (63)
 No 1876 (37)
Diagnosis-source of pain [n (%)]
 1 = SI 1864 (33)
 2 = Facet 2269 (41)
 3 = Disc 18 (0.3)
 4 = Combined 1391 (25)
 5 = Unclear 66 (1)
Patients expectations
 Credibility [mean (SD)] range 0–100 77.1 (17.5)
 Expectancy [mean (SD)] range 0–100 57.8 (17.3)
Rand-36
 Mental [mean (SD)] range 0–100 22.6 (5)
 Physical [mean (SD)] range 0–100 18.5 (4)
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Discussion
Main findings
This study found pain severity and disability both to have 
a statistically significant negative longitudinal relationship 
with health-related quality of life, and a statistically signifi-
cant positive longitudinal relationship with societal as well 
as healthcare costs. In GEE, regression co-efficients have 
a double interpretation resulting in a pooled co-efficient of 
a within-subject and a between-subject effect [22]. Inter-
preting these regression co-efficients in terms of practi-
cal relevance indicates that a 1-point increase in disabil-
ity, for example, is related to a 0.0096 point decrease in 
health-related quality of life (range 0–1), 23 euros increase 
in societal costs and 9 euros increase in healthcare costs 
per 3 months. A clinically relevant increase in disability 
(defined as a 10 point increase on the 0–100 point ODI) [38] 
is thus associated with a decrease in health-related qual-
ity of life by 0.096 points (range 0–1), and an increase in 
societal as well healthcare costs by 230 and 90 euros per 
3-month period. Thus, the potential costs savings associ-
ated with relevant improvements in pain and disability are 
tremendous in a highly prevalent disorder such as low back 
pain. Moreover, a clinically relevant increase in disability 
was found to be longitudinally related to a more than clini-
cally relevant increase in health-related quality of life, which 
was previously found to be equal to an increase of 0.057 or 
more [51, 52]. For pain intensity, the associated decrease in 
health-related quality of life was slightly smaller than the 
established minimal clinically relevant difference for health-
related quality of life (i.e., 0.0041 vs. 0.059).
All of our findings were in line with our expectation that 
pain and disability would have a statistically significant 
negative relationship with health-related quality of life and 
a statistically significant positive longitudinal relationship 
with societal costs and healthcare costs. Also, it is note-
worthy that the impact of pain on health-related quality of 
life and costs was found to be about 2.5 times smaller than 
the impact of disability on health-related quality of life and 
costs even though patients had high baseline scores of pain 
and relatively ‘lower scores’ on disability. This might sug-
gest that it is not the level of pain severity that has a strong 
association with an individual’s health-related quality of life 
and/or costs but the way in which an individual’s pain influ-
ences his or her daily activities. However, further research 
is needed to confirm this.
Comparison with literature
To the best of our knowledge, no studies have explored the 
longitudinal relationships between pain severity and dis-
ability versus health-related quality of life and costs. None-
theless, a cross-sectional study by Sadosky et al. found 
an increasing pain severity to be related with a worsening 
health-related quality of life as well as increased healthcare 
and societal costs. This is in line with the findings of the pre-
sent study. In contract to the present study, however, Sadosky 
et al. also included presenteeism costs (i.e., costs related to 
reduced productivity while being at work) and their study 
was conducted among acute as well as chronic LBP patients 
instead of chronic LBP patients only. Like the present study, 
a study of Stefane et al. found a significant negative associa-
tion between pain and disability versus health-related quality 
Percentages have been rounded off hence values a bit less than 100% and a bit more that 100%
Scores for MPI, Rand 36, patient expectations, health-related quality of life were transformed to a range of 
0–100 to enable comparability. Diagnosis was based on patient history and physical examination
ODI Oswestry disability index, MPI multidimensional pain inventory
Table 1  (continued) Participant characteristic All patients (n = 6316)
Health-related quality of life(utility) [mean (SD)] range 0–100 48 (29)
MPI [mean (SD)] range per subscale 0–100
 Pain severity 22.6 (5.7)
 Interference with daily activities 5.8 (1.9)
 Life control 21.2 (6.3)
 Affective distress 15.4 (4.6)
 Support 28.6 (7.6)
Type of health care insurance [n (%)]
 Basic insurance 633 (12)
 Comprehensive (basic + additional cover) 4630 (86)
 I don’t know 55 (1)
 ODI functional disability [mean (SD)] range 0–100 11.1 (9)
 Pain severity [mean (SD)] range 0–100 73 (16)
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of life. In line with the current study, Stefane et al. found 
health-related quality of life to be more strongly associated 
to disability than to pain. Unlike the present longitudinal 
study, the study of Stefane et al. was cross-sectional in nature 
and disability was measured using the Ronald–Morris 24 
items questionnaire [53] instead of using the ODI.
In our study, disability was found to have about 2.5 times 
higher impact on health-related quality of life, societal costs, 
and healthcare costs. Our reasoning that, this might sug-
gest that, it is not the level of pain severity that has a strong 
association with an individual’s health-related quality of life 
and/or costs but the way in which an individual’s pain influ-
ences his or her daily activities is supported by a study of 
6316 observaonal study paent  were included in the analysis
Baseline
3 months
6 months
9 months 
Educaon:  1094  missing(17%)
Diagnosis:  708 missing (11%)
Paent expectaons : 1062 missing (17%)
Rand-36 mental health: 1068 (17%)
Rand-36 physical health: 1063 (17%)
BMI: 1069 missing (17%)
Health related quality of life 1055 missing (17%)
MPI-Pain severity:1069 missing (17%)
MPI-Interference: 1075 missing (17%)
MPI-Life control: 1075 missing (17%)
MPI-Affecve distress: 1075 missing (17%)
MPI-support: 1071 missing (17%)
NPRS-Pain: 1054 missing (17%)
Employment :2253 missing 36%)
Chronic complaints: 1070 missing (17%)
Recurrent complaints: 1266 missing (20%)
Age: 982 missing (16%)
Gender: 81 missing (1%)
Naonality 989 missing (16%)
Smoking 955 missing (16%)
Health care insuarance 955 missing (16%)
Locaon 60 missing (16%)
Marital status: 60 missing (16%)
ODI : 1059 missing (20%)
ODI: missing 2666 (42%)
NPRS: missing 2646 (42%)
Health related quality of life: missing 2657 (42%)
Cost data: missing 3464 (55%)
12 months 
ODI: 2404 missing (38%)
NPRS: 2159 missing (34%)
Health related quality of life: 2171 missing (34%)
Cost data: 2237 missing (35%)
ODI: missing 3320 (53%)
NPRS: missing 3294(52%)
Health related quality of life: missing 3310 (52%)
Cost data: missing 4043 (64%)
ODI: missing 3881 (61%)
NPRS: missing 3857 (61%)
Health related quality of life: missing 3873 (61%)
Cost data: missing 3967 (63%)
Fig. 1  Flowchart of missing data at each follow-up moment
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Horng et al. In their study, Horng et al. reported that pain 
persistence and limitation of activities for daily living had 
more influence on a patient’s health-related quality of life 
compared to pain severity alone in both acute and chronic 
LBP patients [17]. Our reasoning is further supported by 
Lame et al. who reported pain catastrophizing as the most 
important predictor of individual health-related quality of 
life in a heterogeneous group of chronic pain patients. In 
their study pain catastrophizing had the strongest association 
with individuals health-related quality of life compared to 
pain severity and chronic LBP patients had the lowest qual-
ity of life [54]. Pain catastrophizing is generally defined as 
excessive negative orientation towards pain/noxious stimuli 
[55, 56]. High levels of pain catastrophizing were associated 
with disability, poor outcomes, and pain severity for patients 
with LBP [56–58].
Strengths and limitations
Strengths of the present study include that it is the first study 
to use a longitudinal design to explore whether relationships 
exist between pain severity and disability versus health-
related quality of life and costs. In addition, the large cohort 
of observed patients with chronic LBP patients (n = 6316) 
greatly increases the power of this study. Another advantage 
is the use of imputation methods to deal with missing data 
thereby avoiding complete-case analysis, which would have 
significantly reduced the study’s power and precision. Multi-
ple imputation is the preferred statistical method for dealing 
with missing, particularly when costs are involved [49].
Limitations of the present study include the absence of 
presenteeism costs in the analyses, whereas presenteeism 
more than absenteeism is reported to be disproportionately 
affected by pain [16]. As the results of Sadosky et al. who 
did include presenteeism costs, were in line with those of 
the present study, we do not expect the absence of presen-
teeism costs to have greatly biased our conclusion. None-
theless, future studies should include presenteeism costs to 
give a more accurate representation of true costs related to 
lost productivity. Second, there is an over representation of 
females (66.4%) in the present study, in contrast with the per-
centage of women with LBP in the Netherlands (56%). This 
could have resulted in an underestimation of costs since men 
earn more than women [59] and tend to use more healthcare 
for LBP [60]. Nonetheless, as stratified post hoc analyses 
indicated that, except for one unadjusted analyses, all lon-
gitudinal relationships were statistically significant amongst 
men and women with similar beta co-efficients (Appendix 1), 
Table 2  Longitudinal analyses between disability, societal costs, healthcare costs and health-related quality of life
Scores for health-related quality of life were transformed to a range of 0–100 to enable comparability
a Adjusted for health-related quality of life, physical health, MPI life control, MPI_Inteference, MPI_Pain severity, mental health, disability
b Adjusted for physical health (SF-36), pain impact experience (MPI interference), health-related quality of life (EQ-5D)
c No confounding factors; none of the confounders changed the regression co-efficient by more than 10%
Results disability Crude Adjusted
Disability ODI (0–100) Beta 95% CI Beta 95% CI
Lower bound Upper bound Lower bound Upper bound
Total costs-societal  perspectivea 24 20 29 17 14 20
Total costs-health care  perspectiveb 10 9 12 8 6 9
Health-related quality of  lifec − 0.0096 − 0.0099 − 0.0093
Table 3  Longitudinal analyses between pain, societal costs, healthcare costs and health-related quality of life
a Adjusted for health-related quality of life, physical health, MPI life control, mental health, disability
b Adjusted for MPI life control, MPI_Inteference, MPI_Pain severity, health-related quality of life, physical health (SF-36), mental health
c No confounding factors; none of the confounders changed the regression co-efficient by more than 10%
Results pain Crude Adjusted
Pain (0–100) Beta 95% CI Beta 95% CI
Lower bound Upper bound Lower bound Upper bound
Total costs-societal  perspectivea 8 6 10 5 4 6
Total costs-health care  perspectiveb 3 2 5 2 2 3
Health-related quality of  lifec − 0.0041 − 0.0043 − 0.0038
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we do not expect the overrepresentation of women to have 
severely biased our results and conclusions. Future studies 
should include a larger representation of males, reflecting 
the 44% of males suffering from chronic LBP, to enable bet-
ter generalizability of our results. Third, although mainly 
valid and reliable questionnaires were used, the self-reported 
nature of the questionnaires might have caused recall and or 
social desirability bias. We tried limiting the recall bias by 
minimizing the recall period to 3 months [29]. As it seems 
unlikely that recall bias or the degree to which participants 
gave socially desirable answers systematically differed over 
time, it is not expected that self-report biased the results. 
Fourth, lack of comorbidity factors, which could have been 
potential confounding factors, could have led to underestima-
tion of costs and the impact on health-related quality of life, 
since confounding could not controlled for. Fifth, in the pre-
sent study, the EQ-5D-3L was used to measure health-related 
quality of life, whereas since the inception of the MinT study 
[23], an updated five level version of the EQ-5D has been 
published [61]. However, as both have previously found to 
be valid means to measure health-related quality of life, we 
do expect our reliance on the EQ-5D-3L to have biased our 
results [62]. Also, even though GEE analysis offers an effi-
cient means to analyze the longitudinal relationship between 
variables, its results may heavily depend on the assumptions 
made. That is, with GEE analysis, the adjustment for time is 
carried out by assuming a priori a certain “working” correla-
tion structure for the repeated measurements. Even though 
GEE analysis is assumed to be robust against a wrong choice 
of correlation structure, evidence suggests that results may 
differ extensively across correlation structures [22]. Based 
on the recommendations of Twisk et al. we assumed an 
“exchangeable” correlation structure, in which correlations 
between subsequent measurements are assumed to be equal 
irrespective of the length of the time intervals [22]. To assess 
the robustness of the current findings to the choice of cor-
relation structure, we performed a post hoc analysis with an 
“unstructured” correlation structure, in which no particular 
structure is assumed and all possible correlations between 
repeated measurements have to be estimated [22]. As the 
results of the post hoc analysis are in line with those of the 
main analysis (“Appendix 1”), we consider the current find-
ings to be robust against the choice of correlation structure.
Implications for practice and research
Our findings indicate that the potential costs savings associ-
ated with relevant improvements in pain and disability are 
tremendous in a prevalent disorder such as LBP. A clinical 
improvement in disability, 10 points on the 0–100 point ODI 
[38], will result in potential savings of 230 per LBP patient per 
3 months. Our study also provides some preliminary evidence, 
that is, disability is more associated with higher societal and 
healthcare costs and poorer health-related quality of life, than 
pain severity. Further research into this topic is warranted, but 
for now these findings at least suggest that focussing initiatives 
and interventions on disability more that pain severity may 
improve patient outcomes, i.e., health-related quality of life 
and costs. Also, the aim of the present study was to explore 
the separate relationships of pain and disability with healthcare 
costs, societal costs, and health-related quality of life. There-
fore, the combined influence of pain severity and disability on 
costs and health-related quality of life was not explored, nei-
ther were the potential interactions between pain and disability. 
This should be explored further in future research.
Conclusion
The present study showed that both pain severity and disabil-
ity are longitudinally related to health-related quality of life, 
societal costs, and healthcare costs. Disability had a stronger 
association with all outcomes compared to pain, suggesting 
that it is not the level of pain severity that influences the 
height of an individual’s health-related quality of life and 
costs, but the way in which an individual’s pain influences 
his or her daily activities.
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Appendix 1
See Tables 4, 5, 6, and 7.
Table 4  Longitudinal analyses between disability, societal costs, healthcare costs, and health-related quality of life among men
Scores for health-related quality of life were transformed to a range of 0–100 to enable comparability
a Adjusted for health-related quality of life, physical health, MPI life control, MPI_Inteference, MPI_Pain severity, mental health, disability
b Adjusted for physical health (SF-36), pain impact experience (MPI interference), health-related quality of life (EQ-5D)
c No confounding factors; none of the confounders changed the regression co-efficient by more than 10%
Results disability Crude Adjusted
Disability ODI (0–100) Beta 95% CI Beta 95% CI
Lower bound Upper bound Lower bound Upper bound
Total costs-societal  perspectivea 23 20 25 15 12 18
Total costs-health care  perspectiveb 9 7 11 5 4 7
Health-related quality of  lifec − 0.0094 − 0.0098 − 0.0091
Table 5  Longitudinal analyses between pain, societal costs, healthcare costs, and health-related quality of life among men
a Adjusted for health-related quality of life, physical health, MPI life control, mental health, disability
b Adjusted for MPI life control, MPI_Inteference, MPI_Pain severity, health-related quality of life, physical health (SF-36), mental health
c No confounding factors; none of the confounders changed the regression co-efficient by more than 10%
Results pain Crude Adjusted
Pain (0–100) Beta 95% CI Beta 95% CI
Lower bound Upper bound Lower bound Upper bound
Total costs-societal  perspectivea 4 2 7 2 1 4
Total costs-health care  perspectiveb 2 − 0.4 3 1 0.2 2
Health-related quality of  lifeb − 0.0039 − 0.0041 − 0.0037
Table 6  Longitudinal analyses between disability, societal costs, healthcare costs, and health-related quality of life among women
Scores for health-related quality of life were transformed to a range of 0–100 to enable comparability
a Adjusted for health-related quality of life, physical health, MPI life control, MPI_Inteference, MPI_Pain severity, mental health, disability
b Adjusted for physical health (SF-36), pain impact experience (MPI interference), health-related quality of life (EQ-5D)
c No confounding factors; none of the confounders changed the regression co-efficient by more than 10%
Results disability Crude Adjusted
Disability ODI (0–100) Beta 95% CI Beta 95% CI
Lower bound Upper bound Lower bound Upper bound
Total costs-societal  perspectivea 25 21 30 18 15 22
Total costs-health care  perspectiveb 11 9 13 9 7 10
Health-related quality of  lifec − 0.0096 − 0.0099 − 0.0094
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Appendix 2
See Table 8 and 9.
Table 7  Longitudinal analyses between pain, societal costs, healthcare costs, and health-related quality of life among women
a Adjusted for health-related quality of life, physical health, MPI life control, mental health, disability
b Adjusted for MPI life control, MPI_Inteference, MPI_Pain severity, health-related quality of life, physical health (SF-36), mental health
c No confounding factors; none of the confounders changed the regression co-efficient by more than 10%
Results pain Crude Adjusted
Pain (0–100) Beta 95% CI Beta 95% CI
Lower bound Upper bound Lower bound Upper bound
Total costs-societal  perspectivea 8 7 10 6 5 7
Total costs-health care  perspectiveb 4 3 4 2 2 3
Health-related quality of  lifec − 0.0039 − 0.0041 − 0.0038
Table 8  Longitudinal analyses between disability, societal costs, healthcare costs, and health-related quality of life—using a unstructured cor-
relation structure
Scores for health-related quality of life were transformed to a range of 0–100 to enable comparability
a Adjusted for health-related quality of life, physical health, MPI life control, MPI_Inteference, MPI_Pain severity, mental health, disability
b Adjusted for physical health (SF-36), pain impact experience (MPI interference), health-related quality of life (EQ-5D)
c No confounding factors; none of the confounders changed the regression co-efficient by more than 10%
Results disability Crude Adjusted
Disability ODI (0–100) Beta 95% CI Beta 95% CI
Lower bound Upper bound Lower bound Upper bound
Total costs-societal  perspectivea 25 21 28 17 14 21
Total costs-health care  perspectiveb 11 9 12 8 6 9
Health-related quality of  lifec − 0.0096 − 0.0099 − 0.0093
Table 9  Longitudinal analyses between pain, societal costs, healthcare costs, and health-related quality of life—using an unstructured correlation 
structure
a Adjusted for health-related quality of life, physical health, MPI life control, mental health, disability
b Adjusted for MPI life control, MPI_Inteference, MPI_Pain severity, health-related quality of life, physical health (SF-36), mental health
c No confounding factors; none of the confounders changed the regression co-efficient by more than 10%
Results pain Crude Adjusted
Pain (0–100) Beta 95% CI Beta 95% CI
Lower bound Upper bound Lower bound Upper bound
Total costs-societal  perspectivea 8 7 10 5 4 7
Total costs-health care  perspectiveb 4 3 5 2 2 3
Health-related quality of  lifea − 0.0041 − 0.0043 − 0.0039
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